Impact BioMedical Inc [IBO] stock prices are down -9.81% to $0.87 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The IBO shares have lost -0.20% over the last week, with a monthly amount drifted -6.63%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
The stock price of Impact BioMedical Inc [IBO] has been fluctuating between $0.46 and $6.17 over the past year. Impact BioMedical Inc [AMEX: IBO] shares were valued at $0.87 at the most recent close of the market.
Analyzing the IBO fundamentals
Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at 0.46%, Pretax Profit Margin comes in at -9.8%, and Net Profit Margin reading is -9.8%. To continue investigating profitability, this company’s Return on Assets is posted at -1.66, Equity is -3.05 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.44.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.8091 points at the first support level, and at 0.7498 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.9238, and for the 2nd resistance point, it is at 0.9792.
Ratios To Look Out For
It’s worth pointing out that Impact BioMedical Inc [AMEX:IBO]’s Current Ratio is 0.25. On the other hand, the Quick Ratio is 0.25, and the Cash Ratio is 1.14.
Transactions by insiders
Recent insider trading involved DSS, INC., 10% Owner, that happened on Apr 04 ’25 when 0.89 million shares were sold. Director, Chan Heng Fai Ambrose completed a deal on Apr 03 ’25 to sell 0.35 million shares. Meanwhile, Director Chan Heng Fai Ambrose sold 0.88 million shares on Apr 02 ’25.
